A microneedle developed by Georgia Tech is allowing doctors to deliver medicine directly to the back of a patient’s eye, where inflammation occurs. This targeted delivery helps medication stay where it’s needed longer. That means fewer injections, less pain, and more time between treatments. #WeCanDoThat 🐝